The purpose of one part of this Core is to obtain, preserve, examine, collate, and disseminate postmortem human brain tissue after minimal postmortem delay. Toward this goal we have assembled a staff composed of the Core director, a board certified neuropathologist, histotechnologist, and two 24-hour, on-call pathology technicians. This Core will be responsible for assuring that all brains referred to as AD meet the standard neuropathological criteria. Many of the Core functions, pertaining to the autopsy and histopathological examination, required will be at no cost to our Program as they are part of the routine pathology examination at the McClellan VA Hospital. The McClellan Hospital is new 1,500 bed hospital with a 1,000 bed psychiatric chronic care facility. The Geriatrics Research and Education Core at this facility currently has 400 outpatients. We have been assured of the cooperation of the officials at these institutions, by word, letter, and by our previous collaborations. Another function of the Core, which will more directly involve the director and postdoctoral fellow, will be to provide immunohistochemistry at the light and electronmicroscopic levels, Western immunoblot analysis, and Northern and in situ hybridization services on human tissue samples and cultured cells, upon request. This Core will provide tissues and services that will enhance and facilitate achievement of the aims of the Projects and Cores in this Program, dedicated to providing information about relationships that may form a link between the pathological features of glia, neurons, and extracellular mineral deposits in an age-related disorder, AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010208-02
Application #
3768511
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Mrak, Robert E; Griffin, W Sue T (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26:349-54
Sheng, J G; Mrak, R E; Jones, R A et al. (2001) Neuronal DNA damage correlates with overexpression of interleukin-1beta converting enzyme in APPV717F mice. Neurobiol Aging 22:895-902
Nicoll, J A; Mrak, R E; Graham, D I et al. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47:365-8
Russo, G L; van den Bos , C; Sutton, A et al. (2000) Phosphorylation of Cdc28 and regulation of cell size by the protein kinase CKII in Saccharomyces cerevisiae. Biochem J 351:143-50
Sheng, J G; Zhu, S G; Jones, R A et al. (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol 163:388-91
Griffin, W S; Nicoll, J A; Grimaldi, L M et al. (2000) The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Exp Gerontol 35:481-7
Karson, C N; Mrak, R E; Schluterman, K O et al. (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry 4:39-45
Nishi, M; Azmitia, E C (1999) Agonist- and antagonist-induced plasticity of rat 5-HT1A receptor in hippocampal cell culture. Synapse 31:186-95
Royston, M C; McKenzie, J E; Gentleman, S M et al. (1999) Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition. Neuropathol Appl Neurobiol 25:387-93
Zhu, S G; Sheng, J G; Jones, R A et al. (1999) Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. J Neuropathol Exp Neurol 58:582-7

Showing the most recent 10 out of 59 publications